Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
159.80    1.80 (1.14%)
Bid:
160.20
Ask:
160.40
Spread: 0.20 (0.125%)
Market Cap: £390.01m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

11 Mar 2022 13:50

RNS Number : 5428E
Sabre Insurance Group PLC
11 March 2022
 

11 March 2022

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility ("PDMR") or Connected Persons

 

Sabre announces that on 10 March 2022, the following Directors and PDMRs of the Company acquired a further interest in the Company's shares as a result of their participation in the Company's Share Incentive Plan ("SIP"). The SIP is an all employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy shares in the Company of £0.001 ("Ordinary Shares"), using deductions from salary in each calendar month ("Partnership Shares") and receive allocations of matching free Ordinary Shares ("Matching Shares").

 

Details of the number of Partnership Shares purchased by each Director and PDMR at a price of 200.92 pence per Ordinary Share, and the number of Matching Shares allocated by the SIP Trustees to the Director and PDMR for no consideration are set out below:

 

Name

Number of Partnership Shares Purchased

Number of Matching Shares Acquired

Total of Shares Acquired

Total number of shares held under the SIP

Geoff Carter

Chief Executive Officer

75

25

100

2,940

Trevor Webb

Claims Director

75

25

100

2,940

Matt Wright

Chief Actuary

75

25

100

2,940

 

The transactions were notified to the Company on 11 March 2022.

 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk 

LEI Code: 2138006RXRQ8P8VKGV98

 

 

 

 

 

 

 

 

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

200.92 pence

100

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

100

200.92 pence

 

e)

Date of transaction

10 March 2022

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

200.92 pence

100

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

100

200.92 pence

 

e)

Date of transaction

10 March 2022

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Purchase and Acquisition of Partnership and Matching Shares through the Company's Share Incentive Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

200.92 pence

100

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

100

200.92 pence

 

e)

Date of transaction

10 March 2022

f)

Place of transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXFLFFLXLZBBK
Date   Source Headline
26th Apr 20222:21 pmRNSDirector/PDMR Shareholding
14th Apr 20229:01 amRNSHolding(s) in Company
13th Apr 20224:18 pmRNSNotice of AGM
12th Apr 20223:34 pmRNSDirector/PDMR Shareholding
8th Apr 20228:42 amRNSDirector/PDMR Shareholding
1st Apr 20227:13 amRNSDividend Declaration
1st Apr 20227:00 amRNSBoard Appointment
22nd Mar 20227:00 amRNSFinal Results
14th Mar 20221:22 pmRNSDirector Declaration
11th Mar 20221:50 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSNotice of Results
21st Feb 202212:31 pmRNSHolding(s) in Company
11th Feb 202211:34 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Contract with Freeway Insurance Services Ltd
11th Jan 20222:27 pmRNSDirector/PDMR Shareholding
13th Dec 20211:37 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSAppointment of new additional broker
29th Nov 20217:00 amRNSDirectorate Change
11th Nov 20211:20 pmRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSNew Contract as Exclusive Underwriter to MCE
5th Nov 202111:58 amRNSDirector/PDMR Shareholding
14th Oct 20212:27 pmRNSDirector/PDMR Shareholding
14th Oct 202111:41 amRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 202112:06 pmRNSDirector/PDMR Shareholding
12th Oct 202112:02 pmRNSDirector Declaration
7th Oct 20217:00 amRNSNotice of Trading Update
17th Sep 20212:34 pmRNSDirector/PDMR Shareholding
17th Sep 20212:33 pmRNSDirector/PDMR Shareholding
13th Sep 202111:55 amRNSDirector/PDMR Shareholding
11th Aug 20219:51 amRNSDirector/PDMR Shareholding
30th Jul 202110:15 amRNSDirector/PDMR Shareholding
28th Jul 20213:14 pmRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-year Report
13th Jul 202111:24 amRNSDirector/PDMR Shareholding
13th Jul 20217:00 amRNSNotice of Results
6th Jul 202111:00 amRNSHolding(s) in Company
2nd Jul 202112:50 pmRNSDirector/PDMR Shareholding
29th Jun 202111:39 amRNSHolding(s) in Company
22nd Jun 20213:46 pmRNSHolding(s) in Company
11th Jun 202110:53 amRNSDirector/PDMR Shareholding
21st May 20212:28 pmRNSDirector/PDMR Shareholding
21st May 20212:05 pmRNSDirector/PDMR Shareholding
21st May 202110:34 amRNSDirector/PDMR Shareholding
19th May 202112:49 pmRNSHolding(s) in Company
14th May 202111:46 amRNSResults of Annual General Meeting
14th May 20217:00 amRNSTrading Statement
11th May 20211:20 pmRNSDirector/PDMR Shareholding
22nd Apr 202110:00 amRNSDirector/PDMR Shareholding Replacement
22nd Apr 20219:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.